Evidence map›Paper›PMID 40955822›Full record

ReviewInternational journal of urology : official journal of the Japanese Urological Association2025

Current Status and Future Perspectives of Robotic-Assisted Redo Pyeloplasty for Recurrent Ureteropelvic Junction Obstruction.

Daisuke Ishii, Kohei Mori, Izuru Shiba, Yutaka Shiono, Kazumasa Matsumoto

Abstract readReview
In one paragraph

Review in International journal of urology : official journal of the Japanese Urological Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Current Status and Future Perspectives of Robotic-Assisted Redo Pyeloplasty for Recurrent Ureteropelvic Junction Obstruction.International journal of urology : official journal of the Japanese Urological Association · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Daisuke IshiiDepartment of Urology, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan.ORCID https://orcid.org/0009-0005-2966-6476
Kohei MoriDepartment of Urology, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan.
Izuru ShibaDepartment of Urology, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan.
Yutaka ShionoDepartment of Urology, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan.
Kazumasa MatsumotoDepartment of Urology, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recurrent ureteropelvic junction obstruction presents significant surgical challenges due to fibrosis, altered anatomy, and impaired vascularity. Open redo pyeloplasty has traditionally been the gold standard; however, it is associated with considerable morbidity. Minimally invasive options such as endopyelotomy and laparoscopic pyeloplasty offer faster recovery but have lower success rates and greater technical complexity. In this review, we aimed to provide a comprehensive evaluation of the current literature on robot-assisted surgical management of recurrent ureteropelvic junction obstruction. Robot-assisted laparoscopic pyeloplasty has emerged as a promising alternative, providing enhanced visualization, improved dexterity, and precise suturing, even in reoperative cases. Redo robot-assisted laparoscopic pyeloplasty achieves high success rates (75%-100%) with low complication rates and shorter hospital stays compared with open or conventional laparoscopic approaches. Moreover, advanced robotic techniques-including ureterocalicostomy, buccal mucosa graft ureteroplasty, ileal ureter replacement, and renal autotransplantation-have broadened reconstructive options for complex or recurrent cases. Single-port robotic platforms are also gaining interest for their potential to reduce invasiveness and improve cosmetic outcomes. Despite favorable outcomes, existing evidence is primarily limited to retrospective, single-institution studies. Further prospective, multicenter research is needed to validate long-term efficacy and cost-effectiveness. Surgeon expertise, careful patient selection, and adherence to standardized protocols remain essential for optimizing outcomes. As robotic technology continues to evolve, robotic redo pyeloplasty and it's adjunct procedures are increasingly considered preferred treatment modalities for recurrent or anatomically complex ureteropelvic junction obstruction.

Indexed as

Kidney PelvisLaparoscopyReoperationRobotic Surgical ProceduresUreteral ObstructionUrologic Surgical ProceduresHumansRecurrenceTreatment Outcomerecurrent ureteropelvic junction obstructionredo pyeloplastyrobotic surgeryureteropelvic junction obstruction

Identifiers

PMID40955822
PMCPMC12687925

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.